|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date30 Mar 2007 |
|
MechanismCav2.1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.DE |
First Approval Date01 Jan 1975 |
100 Clinical Results associated with Saile Pharmaceutical Technology (Shanghai) Co., Ltd.
0 Patents (Medical) associated with Saile Pharmaceutical Technology (Shanghai) Co., Ltd.
100 Deals associated with Saile Pharmaceutical Technology (Shanghai) Co., Ltd.
100 Translational Medicine associated with Saile Pharmaceutical Technology (Shanghai) Co., Ltd.